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In an elegant meta-analysis published 5 years ago, Bavry et al.
(1) reported that aspiration thrombectomy prior to percuta-
neous coronary intervention (PCI) in acute ST segment–
elevation myocardial infarction (STEMI) can be beneﬁcial.
Using data from 30 studies of 6,415 patients, they found
improvements in 2 surrogate markers of coronary ﬂow
and reperfusion, with more Thrombolysis In Myocardial
Infarction (TIMI) blush grade of 3 at the conclusion of the
procedure, and more ST-segment resolution (STR) in the
group with aspiration thrombectomy compared with PCI
without thrombectomy. More important, at a mean follow-up
interval of 5 months, mortality was 2.7% in the aspiration
thrombectomy group compared with 4.4% in the PCI-only
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group (p ¼ 0.018). Neither mechanical thrombectomy nor
embolic protection devices were found to provide similar
beneﬁts or any beneﬁt at all in the meta-analysis. Subse-
quently, the American College of Cardiology/American
Heart Association (ACC/AHA) STEMI guidelines
endorsed the use of aspiration thrombectomy with PCI in
STEMI, with a Class IIa (Level of Evidence: B) recom-
mendation (2). The recently updated 2013 ACCF/AHA
STEMI guidelines retain this endorsement (3). Nonethe-
less, the use of aspiration thrombectomy during PCI in
STEMI has remained controversial. On one hand, removal
of some or possibly most of the offending thrombus at the
culprit lesion site may prevent distal embolization, improve
epicardial coronary ﬂow, and reduce microvascular obstruc-
tion and the no-reﬂow phenomenon. On the other hand,
the thrombectomy catheter itself is one more device that may
cause distal thrombus embolization, and its insertion adds
procedure time prior to deﬁnitive balloon angioplasty and/or
stenting. Not everyone is convinced there is beneﬁt. Partly
this is because there has been a great deal of heterogeneity
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the contents of this paper to disclose.small, as was documented in the meta-analysis (1). The
recently reported TROFI (Thrombus Aspiration on Flow
Area in Patients With ST-Elevation Myocardial Infarction)
trial (4) is likely not of much help either. Using optical
frequency domain imaging, the TROFI investigators found
in 141 STEMI patients that minimal ﬂow area at the lesion
site was no different when aspiration thrombectomy was
performed prior to stenting compared with stenting alone.
What that ﬁnding might mean is unknown at present.
Myocardial blush grades, STR, and clinical events also were
not different, but the TROFI trial was not designed or
powered for those secondary outcomes.
Meanwhile, in this issue of the Journal, Kumbhani et al. (5)
of the previous meta-analysis have now updated their work
with several important additions. A completely new meta-
analysis was done, and this one included 5,534 patients from
25 trials. In addition to TIMI blush grades, STR, and
intermediate-term mortality, the authors also examined data on
infarct size, left ventricular function (ejection fraction; LVEF),
and total ischemic time, hoping to gain insight into mecha-
nisms of beneﬁt. Similar to their previous ﬁndings, both TIMI
blush grade 3 and STR were signiﬁcantly better with aspiration
thrombectomy compared with PCI only, and mortality at 6
months was lower (2.7% vs. 3.9%; p ¼ 0.049). Mechanical
thrombectomy again did not exhibit beneﬁt compared with
PCI alone. The data extracted regarding infarct size and LVEF
are interesting but not conclusive, and this further reinforces
the need for larger randomized trials that address these clinical
measures directly using uniform methods. In the trials included
in this meta-analysis, the follow-up assessments of infarct size
and LVEF were done at a mean of 36 days (range: from
hospital discharge to 6 months) and involved a variety of
methods, including echocardiography, radionuclide perfusion
studies, and magnetic resonance imaging. Selection bias,
survival bias, and incomplete follow-up no doubt interfered
with the comparisons, and it is not surprising that there were
no differences in infarct size (mean: 17.1% vs. 17.3%; p ¼
0.64) or LVEF (mean: 53.0% vs. 52.8%; p¼ 0.32). Also, these
relatively smaller infarcts and essentially normal LVEFs,
coupled with the relatively lower mortalities, all suggest that
stringent clinical selection allowed only less clinically ill patients
into the trials. Again, this is no surprise.
Finally, it is important and noteworthy that these authors
extracted ischemic times, which they are careful to deﬁne as
total ischemic time, generally taken to be the time from onset
of infarct symptoms until device activation. Mean ischemic
times in these studies ranged from 2.4 h to 7.6 h. We and
others have shown that total ischemic time is the correct
focus of attention for reperfusion in STEMI (6,7). To fur-
ther illustrate its importance, we used the ischemic time
and infarct size data reported in the present meta-analysis
(Fig. 1). Based on data from studies in animals and hu-
mans, it appears that a total ischemic time of <120 min is
a worthwhile and achievable goal to keep infarct size as small
as possible andmortality as low as possible. The present meta-
analysis data do not contradict this. In conclusion, the proper
Figure 1 Ischemic Time Versus Infarct Size
The x-axis shows mean ischemic time in hours. The y-axis shows infarct size as
a percentage of left ventricle. A simple regression line is shown; the data points
are nonadjusted and nonweighted. Data from Tables 1 and 2 in the paper by
Kumbhani et al. (5).
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1420interpretation of this newly updated meta-analysis is that, like
its predecessor, it provides solid, if indirect, evidence that
aspiration thrombectomy prior to PCI in STEMI is useful
and, like all infarct treatments, should be applied as early as
possible, ideally within 120 min of ischemic time. We agree
with the authors that until larger clinical trials are done, the
present ACCF/AHA STEMI guideline recommendation
(Class IIa, Level of Evidence: B) remains appropriate.
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